187 related articles for article (PubMed ID: 16208147)
1. Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease.
Pizzolo F; Pavan C; Guarini P; Trabetti E; Girelli D; Corrocher R; Olivieri O
J Hypertens; 2005 Nov; 23(11):2041-7. PubMed ID: 16208147
[TBL] [Abstract][Full Text] [Related]
2. [Successful percutaneous angioplasty of renal artery in a patient with severe arterial hypertension and symptoms of hyperaldosteronism: a case report].
Skrzypiec-Spring M; Spring A; Poczatek K; Nowicki P; Derkacz A; Ciesielska A; Negrusz-Kawecka M; Mazurek W
Kardiol Pol; 2006 Jul; 64(7):724-6; discussion 726-7. PubMed ID: 16886129
[TBL] [Abstract][Full Text] [Related]
3. Impact of endovascular treatment of atherosclerotic renal artery stenosis on endothelial function and arterial blood pressure.
Jacomella V; Husmann M; Thalhammer C; Uike K; Pfammatter T; Amann-Vesti B
Int Angiol; 2012 Feb; 31(1):70-6. PubMed ID: 22330627
[TBL] [Abstract][Full Text] [Related]
4. Endovascular therapy of renovascular hypertension in children: single center analysis.
Radanović B; Cacić Z; Perkov D; Smiljanić R; Corić SR; Ilakovac K
Eur J Pediatr Surg; 2009 Jun; 19(3):135-40. PubMed ID: 19360546
[TBL] [Abstract][Full Text] [Related]
5. Long-term results after percutaneous transluminal angioplasty of atherosclerotic renal artery stenosis--the importance of intensive follow-up.
Weibull H; Bergqvist D; Jonsson K; Hulthén L; Mannhem P; Bergentz SE
Eur J Vasc Surg; 1991 Jun; 5(3):291-301. PubMed ID: 1830855
[TBL] [Abstract][Full Text] [Related]
6. Surgery after failed percutaneous renal artery angioplasty.
Wong JM; Hansen KJ; Oskin TC; Craven TE; Plonk GW; Ligush J; Dean RH
J Vasc Surg; 1999 Sep; 30(3):468-82. PubMed ID: 10477640
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous transluminal renal angioplasty in aortoarteritis.
Deyu Z; Lisheng L; Ruping D; Haiying W; Guozhang L
Int J Cardiol; 1998 Oct; 66 Suppl 1():S205-11. PubMed ID: 9951821
[TBL] [Abstract][Full Text] [Related]
8. Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.
Corriere MA; Pearce JD; Edwards MS; Stafford JM; Hansen KJ
J Vasc Surg; 2008 Sep; 48(3):580-7; discussion 587-8. PubMed ID: 18727962
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study.
Rocha-Singh K; Jaff MR; Rosenfield K;
J Am Coll Cardiol; 2005 Sep; 46(5):776-83. PubMed ID: 16139124
[TBL] [Abstract][Full Text] [Related]
10. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
[TBL] [Abstract][Full Text] [Related]
11. [Renovascular hypertension: is it only the top of the iceberg?].
Lewandowski J
Pol Merkur Lekarski; 2003 Oct; 15(88):371-5; discussion 375-6. PubMed ID: 14974369
[TBL] [Abstract][Full Text] [Related]
12. Sustained beneficial effects on blood pressure during long time retrospective follow-up after endovascular treatment of renal artery occlusion.
Alhadad A; Mattiasson I; Ivancev K; Gottsäter A; Lindblad B
J Hum Hypertens; 2004 Oct; 18(10):739-44. PubMed ID: 15085169
[TBL] [Abstract][Full Text] [Related]
13. Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.
Takamiya Y; Okamura K; Shirai K; Urata H
Am J Case Rep; 2019 Nov; 20():1684-1690. PubMed ID: 31732710
[TBL] [Abstract][Full Text] [Related]
14. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
Jaff MR; Bates M; Sullivan T; Popma J; Gao X; Zaugg M; Verta P;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):343-50. PubMed ID: 22511402
[TBL] [Abstract][Full Text] [Related]
15. Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis.
Rocha-Singh KJ; Novack V; Pencina M; D'Agostino R; Ansel G; Rosenfield K; Jaff MR
Catheter Cardiovasc Interv; 2011 Nov; 78(5):779-89. PubMed ID: 21648052
[TBL] [Abstract][Full Text] [Related]
16. Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty.
Teunissen KE; Postma CT; van Jaarsveld BC; Derkx FH; Thien T
J Hypertens; 1997 Dec; 15(12 Pt 2):1791-6. PubMed ID: 9488241
[TBL] [Abstract][Full Text] [Related]
17. Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis.
Alhadad A; Mattiasson I; Ivancev K; Lindblad B; Gottsäter A
Int Angiol; 2009 Apr; 28(2):106-12. PubMed ID: 19367240
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).
Balzer KM; Pfeiffer T; Rossbach S; Voiculescu A; Mödder U; Godehardt E; Sandmann W
J Vasc Surg; 2009 Mar; 49(3):667-74; discussion 674-5. PubMed ID: 19135837
[TBL] [Abstract][Full Text] [Related]
19. Outcome after endovascular revascularization of atherosclerotic renal artery stenosis.
Eklöf H; Bergqvist D; Hägg A; Nyman R
Acta Radiol; 2009 Apr; 50(3):256-64. PubMed ID: 19172426
[TBL] [Abstract][Full Text] [Related]
20. Reversible renin-dependent renovascular hypertension successfully treated with percutaneous transluminal renal angioplasty and stenting.
Fang BR; Lin CY
Int Heart J; 2005 Mar; 46(2):339-45. PubMed ID: 15876819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
